Fabrication and Characterisation of Lavender Oil and Plant Phospholipid Based Sumatriptan Succinate Hybrid Nano Lipid Carriers

Publish Year: 1399
نوع سند: مقاله ژورنالی
زبان: English
View: 67

This Paper With 14 Page And PDF Format Ready To Download

  • Certificate
  • من نویسنده این مقاله هستم

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این Paper:

شناسه ملی سند علمی:

JR_PBRE-6-1_008

تاریخ نمایه سازی: 10 دی 1402

Abstract:

Background:  Nanostructured lipid carriers (NLCs) of sumatriptan succinate (SS) were prepared by using lavender oil.  In ancient days, lavender oil was used for the treatment of a migraine. The natural anti-migraine agent, lavender oil, combined with an anti-migraine drug such as SS in a nano-formulation, will be a practical alternative approach in migraine therapy.  Objective: NLCs of sumatriptan succinate were fabricated by using a natural anti-migraine oil (lavender oil), LECIVA-S۷۰, which is a specialized grade for liposomal dermatological preparation and designed for emulsion, fat infusions, nutraceutical formulations, and parenteral use. It contains ۷۰% phosphatidylcholine, which is not generally present in the regular soy lecithin. Methods: The central composite design technique was used to examine the relationship between independent variables and responses such as lavender oil and LECIVA-S۷۰. The dependent variables were Z-average (R۱), polydispersity index (R۲), and % entrapment efficiency (R۳).  The NLCs were prepared with the double emulsification technique.  The Fourier transform infrared spectroscopy, X-ray diffraction, and differential scanning calorimetry analyzed the drug excipient compatibility profile. The developed NLCs were characterized for particle size by using Mastersizer, Zetasizer, and transmission electron microscopy.  The membrane diffusion technique studied the in vitro drug release profile. Results: The mean±SD size of the NLCs ranged from ۴۱۱.۴±۳۱۱.۱ d.nm to ۳۹۸.۸±۲۴۲.۶ d.nm. The best formulation (SNE۹) demonstrated an average diameter of ۳۹۸.۸±۲۴۲.۶ d.nm, with the PDI of ۰.۲۱۶, and zeta potential of ۱۷.۱۸ mV. Conclusion: The optimized formula demonstrated the narrow size range, a satisfactory zeta potential, high drug loading, and reproducible drug release profile. The NLCs successfully retained the aroma of the lavender oil. According to ANOVA, the polydispersity index (R۲) is significant with the central composite design.

Keywords:

Nanostructured lipid carriers (NLCs) , Zetasizer , Zeta potential , Transmission electron microscopy (TEM)

Authors

Reeta

Rayat-Bahra Institute of Pharmacy, Rayat-Bahra University, Punjab, India

Rashid Mehmood

School of Materials Science and Engineering, UNSW Sydney, NSW, Australia

Maria John Newton Amaldoss

School of Materials Science and Engineering, UNSW Sydney, NSW, Australia

مراجع و منابع این Paper:

لیست زیر مراجع و منابع استفاده شده در این Paper را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود Paper لینک شده اند :
  • Talegaonkar S, Bhattacharyya A. Potential of Lipid Nanoparticles (SLNs and ...
  • Li Q, Cai T, Huang Y, Xia X, Cole SPC, ...
  • Mukherjee S, Ray S, Thakur RS. Solid lipid nanoparticles: a ...
  • Naseri N, Valizadeh H, Zakeri-Milani P. Solid Lipid Nanoparticles and ...
  • Mishra V, Bansal KK, Verma A, Yadav N, Thakur S, ...
  • Saunders EFH, Nazir R, Kamali M, Ryan KA, Evans S, ...
  • Djupesland PG. Nasal drug delivery devices: characteristics and performance in ...
  • Bruno BJ, Miller GD, Lim CS. Basics and recent advances ...
  • Touitou E, Illum L. Nasal drug delivery. Drug Deliv Transl ...
  • van Hoogevest P, Wendel A. The use of natural and ...
  • Koulivand PH, Khaleghi Ghadiri M, Gorji A. Lavender and the ...
  • Sasannejad P, Saeedi M, Shoeibi A, Gorji A, Abbasi M, ...
  • Cologno D, Mazzeo A, Lecce B, Mundi C, Petretta V, ...
  • Kayser V, Aubel B, Hamon M, Bourgoin S. The antimigraine ...
  • Fullerton T, Gengo FM. Sumatriptan: A Selective ۵-Hydroxytryptamine Receptor Agonist ...
  • Ishkanian G, Blumenthal H, Webster CJ, Richardson MS, Ames M. ...
  • Hansraj GP, Singh SK, Kumar P. Sumatriptan succinate loaded chitosan ...
  • Kamel AO, Awad GAS, Geneidi AS, Mortada ND. Preparation of ...
  • Thatipamula R, Palem C, Gannu R, Mudragada S, Yamsani M. ...
  • Venkateswarlu V, Manjunath K. Preparation, characterization and in vitro release ...
  • نمایش کامل مراجع